Rbm8a deficiency causes hematopoietic defects by modulating Wnt/PCP signaling

Key Points

• Hematopoietic defects arise due to rbm8a deficiency, affecting cell development and function.
• The disruption alters Wnt/PCP signaling pathways, leading to significant developmental changes.
• Observational analysis suggests that the interference in signaling directly correlates with hematopoietic issues observed.
• Findings highlight potential therapeutic targets related to rbm8a deficiency and Wnt/PCP signaling.